» Articles » PMID: 34064555

Silver Nanoparticles Conjugated with Contact Lens Solutions May Reduce the Risk of Keratitis

Abstract

keratitis (AK), a severe sight-threatening corneal infection, has become a significant medical problem, especially among contact lens wearers. The disease manifests as eye pain, congestion, blurred vision, lachrymation, and ring-shaped infiltrates of the cornea, and can lead to permanent blindness. Inappropriate habits of contact lens users may result in an increased risk of AK infection. The anti-amoebic efficiency of popular multipurpose contact lens solutions is insufficient to reduce this risk. An effective and non-toxic therapy against AK has not yet been developed. The prevention of AK is crucial to reduce the number of AK infections. Nanoparticles are known to be active agents against bacteria, viruses, and fungi and were also recently tested against protozoa, including spp. In our previous studies, we proved the anti-amoebic and anti-adhesive activity of silver nanoparticles against . The aim of this study is to evaluate the activity, cytotoxicity, and anti-adhesive properties of silver nanoparticles conjugated with five commonly used multipurpose contact lens solutions against the NEFF strain. The obtained results show a significant increase in anti-amoebic activity, without increasing the overall cytotoxicity, of Solo Care Aqua and Opti Free conjugated with nanoparticles. The adhesion of trophozoites to the contact lens surface is also significantly reduced. We conclude that low concentrations of silver nanoparticles can be used as an ingredient in contact lens solutions to decrease the risk of keratitis infection.

Citing Articles

Recent Nanotechnological Trends in the Management of Microbial Keratitis.

Jaiswal S, Shinde P, Tale V J Ophthalmic Vis Res. 2025; 19(4):476-487.

PMID: 39917459 PMC: 11795005. DOI: 10.18502/jovr.v19i4.14498.


trophozoites that survive multipurpose solutions are able to adhere to cosmetic contact lenses, increasing the risk of infection.

Hernandez-Martinez D, Castro Pot E, Hernandez Olmos P, Hernandez E, Cobos D, Villa Ramirez S Heliyon. 2023; 9(9):e19599.

PMID: 37809484 PMC: 10558846. DOI: 10.1016/j.heliyon.2023.e19599.


Nanomedical research and development in Spain: improving the treatment of diseases from the nanoscale.

Fernandez-Gomez P, Perez de la Lastra Aranda C, Tosat-Bitrian C, Bueso de Barrio J, Thompson S, Sot B Front Bioeng Biotechnol. 2023; 11:1191327.

PMID: 37545884 PMC: 10401050. DOI: 10.3389/fbioe.2023.1191327.


Antimicrobial Performance of Innovative Functionalized Surfaces Based on Enamel Coatings: The Effect of Silver-Based Additives on the Antibacterial and Antifungal Activity.

Rehman H, Russo F, Calovi M, Massidda O, Rossi S Int J Mol Sci. 2023; 24(3).

PMID: 36768684 PMC: 9916675. DOI: 10.3390/ijms24032364.


Mediated Selenium Nanoparticles-Antibiotics Combinations against sp.

Nikam P, Salunkhe J, Marathe K, Alghuthaymi M, Abd-Elsalam K, Patil S Microorganisms. 2022; 10(12).

PMID: 36557755 PMC: 9785558. DOI: 10.3390/microorganisms10122502.


References
1.
Emmanuel R, Palanisamy S, Chen S, Chelladurai K, Padmavathy S, Saravanan M . Antimicrobial efficacy of green synthesized drug blended silver nanoparticles against dental caries and periodontal disease causing microorganisms. Mater Sci Eng C Mater Biol Appl. 2015; 56:374-9. DOI: 10.1016/j.msec.2015.06.033. View

2.
Anwar A, Siddiqui R, Raza Shah M, Khan N . Antidiabetic Drugs and Their Nanoconjugates Repurposed as Novel Antimicrobial Agents against Acanthamoeba . J Microbiol Biotechnol. 2019; 29(5):713-720. DOI: 10.4014/jmb/1903.03009. View

3.
Lorenzo-Morales J, Khan N, Walochnik J . An update on Acanthamoeba keratitis: diagnosis, pathogenesis and treatment. Parasite. 2015; 22:10. PMC: 4330640. DOI: 10.1051/parasite/2015010. View

4.
Rahimi M, Ahmadpour E, Esboei B, Spotin A, Kohansal Koshki M, Alizadeh A . Scolicidal activity of biosynthesized silver nanoparticles against Echinococcus granulosus protoscolices. Int J Surg. 2015; 19:128-33. DOI: 10.1016/j.ijsu.2015.05.043. View

5.
Dart J, Saw V, Kilvington S . Acanthamoeba keratitis: diagnosis and treatment update 2009. Am J Ophthalmol. 2009; 148(4):487-499.e2. DOI: 10.1016/j.ajo.2009.06.009. View